Cardiol Therapeutics Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-11
Interim MD&A - English.pdf
Results 2026-05-11
Interim financial statements/report – English.pdf
Transactions 2026-05-08 Financing
Pricing supplement (other than specified derivative) – English.pdf
Results 2026-05-07
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
News release - English.pdf
News 2026-04-28
Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program
News release - English.pdf
News 2026-04-14
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
News release - English.pdf
Results 2026-04-01
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
News release - English.pdf
Results 2026-03-31
Annual information form - English.pdf
Results 2026-03-31
Annual MD&A - English.pdf
Results 2026-03-31
Audited annual financial statements – English.pdf
News 2026-02-25
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
News release - English.pdf
News 2026-02-11
Report of exempt distribution (45-106F1) (amended).pdf
Results 2026-02-10
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
News release - English.pdf
News 2026-02-09
Alternative monthly report.pdf
Transactions 2026-02-02
Other material contracts - English.pdf
Transactions 2026-02-02
Other material contracts - English.pdf
News 2026-02-02
Report of exempt distribution (45-106F1).pdf
Transactions 2026-01-26 Financing
Cardiol Therapeutics Inc. Announces Bought Deal Private Placement Offering of Units for Gross Proceeds of $13.5 Million
Material change report - English.pdf
Transactions 2026-01-23 Financing
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
News release - English.pdf
Transactions 2026-01-16 Financing
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
News release - English.pdf
News 2026-01-16
Offering document - English.pdf
Results 2026-01-13
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
News release - English.pdf
Results 2025-12-01
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
News release - English.pdf
Results 2025-11-13 Financials
Interim MD&A - English.pdf
Results 2025-11-13 Financials
Interim financial statements/report – English.pdf
News 2025-11-13
News release - English.pdf
News 2025-11-06
Other.pdf
News 2025-11-06
Other.pdf
News 2025-11-06
Other.pdf
News 2025-11-06
Other.pdf
News 2025-11-06
Consent letter of issuer's legal counsel.pdf
News 2025-11-06
Auditors' consent letter.pdf
Transactions 2025-11-06
Prospectus (non pricing) supplement (other than ATM) – English.pdf
News 2025-11-05
Decision Document (Subsequent Amendment to Final).pdf
News 2025-11-05
News release - English.pdf
Transactions 2025-10-30 Financing
Amendment to (or amended) final short form prospectus – English.pdf
News 2025-10-27
Report of exempt distribution (45-106F1).pdf
News 2025-10-27
Material change report - English.pdf
Ownership 2025-10-22
2 insiders · +$150k net
Insider trading – 2025-10-22
2 insiders · +$150k net
News 2025-10-21
News release - English.pdf
News 2025-10-17
News release - English.pdf
Results 2025-08-14 Financials
Interim MD&A - English.pdf
Results 2025-08-14 Financials
Interim financial statements/report – English.pdf
News 2025-08-11
News release - English.pdf
News 2025-08-06
News release - English.pdf
News 2025-07-22
News release - English.pdf
Ownership 2024-12-26
Torre, Guillermo bought +$22k
Insider trading – 2024-12-26
1 insider · +$22k net
Ownership 2024-12-24
Hamer, Andrew Warwick bought +$25k
Insider trading – 2024-12-24
1 insider · +$25k net
Ownership 2024-12-23
Torre, Guillermo bought +$28k
Insider trading – 2024-12-23
1 insider · +$28k net
Ownership 2024-12-18
PEKOS, PETER bought +$50k
Insider trading – 2024-12-18
1 insider · +$50k net
Ownership 2024-12-17
3 insiders · +$144k net
Insider trading – 2024-12-17
3 insiders · +$144k net
Ownership 2024-06-24
Elsley, David bought +$138k
Insider trading – 2024-06-24
1 insider · +$138k net